image vol u lift glp 1 4d skin rebound complex VOL.U.LIFT™ GLP-1 — Fine Line Seattle and astaxanthin VOL.U.LIFT™ GLP-1 4D Skin Rebound

A 2025 Nature Communications paper mapped the binding to the disordered transactivation domain of p53, adding structural detail to how FOXO4-DRI engages its target

Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy

"Ipamorelin selectively releases GH in both animals and humans without increasing ACTH, cortisol or prolactin, even at doses up to 200 times higher than the ED50 for GH release." Raun et al., Eur J Endocrinol (1998) This is the single cleanest thing about ipamorelin relative to older GHRPs no meaningful cortisol or prolactin noise, so you don't have to manage that on top of everything else

(grant no